MedPath

RELATION BETWEEN EGG/EMBRYO FORMATION WITH USING EGG FORMING DRUGS (TABLET CLOMIPHENE CITRATE)

Not Applicable
Conditions
Health Condition 1: N979- Female infertility, unspecified
Registration Number
CTRI/2020/10/028563
Lead Sponsor
Kasturba Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Women aged between 18 years and 35 years with

infertility,

Body mass index < 30 kg/m2,

Women with patency of at least one fallopian tube.

Women with PCOS

Exclusion Criteria

Endometriosis,

Women with AMH level less than 1.5,

Women with bilateral tubal blockage,

Abnormal HSA of Male partner.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1). AMH value will be correlated with ovulation in 3 <br/ ><br>different groups- <br/ ><br> <br/ ><br>1.AMH- 1.5 to 3.5 , <br/ ><br> <br/ ><br>2.AMH- 3.5 to 5.5, <br/ ><br> <br/ ><br>3.AMH- 5.5. <br/ ><br> <br/ ><br>Timepoint: MAY 2020 TO DECEMBER 2021
Secondary Outcome Measures
NameTimeMethod
2).Evidence of Ovulation rates with <br/ ><br>varying doses of Clomiphene Citrate.Timepoint: MAY 2020 TO DECEMBER 2021
© Copyright 2025. All Rights Reserved by MedPath